Form 4: Marcus Corp. Exec Receives Significant Stock Grant
Insider Transaction Report
Mark A. Gramz, President of Marcus Theatres, was granted 16,400 shares of common stock in The Marcus Corporation, increasing his beneficial ownership.
Summary
- Mark A. Gramz, President of Marcus Theatres, acquired 16,400 shares of The Marcus Corporation (MCS) common stock on February 11, 2026.
- The acquisition was a restricted stock grant at a price of $0 per share.
- These restricted shares will vest 50% after the second anniversary and 100% after the third anniversary of the grant date.
- Following this transaction, Gramz directly beneficially owns a total of 52,161 shares of common stock.
- Gramz also holds various stock options to buy common stock, with exercise prices ranging from $12.71 to $41.90 and expiration dates between February 2027 and March 2033.
- The stock options have different vesting schedules, generally vesting over 2 to 5 years from their original grant dates.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, indicating continued executive commitment and alignment with shareholder interests through equity-based compensation, which is a standard practice.
Positives
- The grant of 16,400 restricted shares to a key executive, Mark A. Gramz, aligns his interests with the company's long-term shareholder value.
- The zero-cost acquisition price for the restricted stock indicates an incentive-based compensation, typically tied to performance or retention.
Risks
- The value of the restricted stock and stock options is directly dependent on the future market performance of The Marcus Corporation's common stock.
- The vesting schedules mean that the executive's full ownership of the granted shares is contingent on continued employment and the passage of time.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance beyond the vesting schedules of the granted securities.
Industry Context
StockSavvy.ai notes that executive stock grants are a common practice in the entertainment and hospitality industry, including cinema and hotel operators like The Marcus Corporation, to incentivize long-term performance and align management interests with shareholder returns. Such grants are typically part of a broader executive compensation strategy.
Comparison to Industry Standards
- The grant of restricted stock with multi-year vesting is a standard compensation practice, comparable to schemes seen at peers like AMC Entertainment Holdings (AMC) or Cinemark Holdings (CNK), where executive incentives are often tied to stock performance and retention.
- The mix of restricted stock and stock options is also a common structure, aiming to provide both immediate equity interest and future upside potential, similar to compensation packages at other mid-cap leisure and entertainment companies.
Stakeholder Impact
- Shareholders: The grant aligns executive incentives with long-term shareholder value, potentially fostering better performance.
- Employees: May signal stability in executive leadership and a commitment to retaining key talent.
Next Steps
- The restricted stock granted on February 11, 2026, will vest 50% after its second anniversary and 100% after its third anniversary.
- Various stock options will continue to vest according to their respective schedules (e.g., 40-100% over 2-5 years or 50-100% over 2-4 years).
Key Dates
| Date | Description |
|---|---|
| 02/11/2026 | Date of restricted stock grant and earliest transaction date. |
| 02/13/2026 | Signature date of the reporting person's attorney-in-fact. |
| 02/28/2027 | Expiration date for stock options with an exercise price of $31.2. |
| 02/27/2028 | Expiration date for stock options with an exercise price of $27. |
| 02/26/2029 | Expiration date for stock options with an exercise price of $41.9. |
| 02/25/2030 | Expiration date for stock options with an exercise price of $28.88. |
| 05/08/2030 | Expiration date for stock options with an exercise price of $12.71. |
| 03/09/2031 | Expiration date for stock options with an exercise price of $21.84. |
| 03/08/2032 | Expiration date for stock options with an exercise price of $17.04. |
| 03/07/2033 | Expiration date for stock options with an exercise price of $15.99. |
Recommendation
holdThis Form 4 filing reports a routine executive compensation grant of restricted stock and details existing stock option holdings. While it indicates continued alignment of executive interests with the company's long-term performance, it does not provide new information that would fundamentally alter the investment thesis for The Marcus Corporation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.
Keywords
Marcus Corporation, MCS, Form 4, Insider Transaction, Stock Grant, Restricted Stock, Stock Options, Executive Compensation, Mark A. Gramz, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.